A High Model for End-stage Liver Disease Score Should Not Be Considered a Contraindication to Living Donor Liver Transplantation
K.-S. Poon(China Medical University), Ping-Huei Tsai(Chung Shan Medical University Hospital), Wen‐Pang Su(China Medical University), Y.-F. Chen(China Medical University), Long-Bin Jeng(China Medical University), Cheng‐Yuan Peng(China Medical University), Chun‐Chieh Yeh(China Medical University), Horng-Ren Yang(Chang Gung University), Ping‐Chun Li(China Medical University), T.-H. Chen(China Medical University), Yung‐Jen Ho(China Medical University), Hsueh‐Chou Lai(China Medical University), C.-C. Lee(Pingtung Christian Hospital)
Cited by 18
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy
|Annals of Internal Medicine|2016|364
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|The Lancet|2014|343
Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
|Molecular and Cellular Biology|1994|284